Alembic Pharmaceuticals Limited (NSE:APLLTD)
India · Delayed Price · Currency is INR 764.25
+6.75 (0.89%)
Apr 21, 2026, 3:20 PM IST
Alembic Pharmaceuticals Market Cap
Alembic Pharmaceuticals has a market cap or net worth of 148.9 billion as of April 21, 2026. Its market cap has decreased by -16.29% in one year.
Market Cap
148.90B
Enterprise Value
162.32B
Revenue
72.67B
Ranking
n/a
PE Ratio
23.62
Stock Price
764.25
Market Cap Chart
Since September 21, 2011, Alembic Pharmaceuticals's market cap has increased from 9.00B to 148.90B, an increase of 1,554.11%. That is a compound annual growth rate of 21.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 148.90B | -10.48% |
| Dec 31, 2025 | 166.32B | -20.64% |
| Dec 31, 2024 | 209.59B | 40.41% |
| Dec 29, 2023 | 149.27B | 32.55% |
| Dec 30, 2022 | 112.61B | -28.56% |
| Dec 31, 2021 | 157.62B | -22.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 317.01B |
| Gland Pharma | 296.13B |
| Wockhardt | 226.73B |
| NATCO Pharma | 200.55B |
| Eris Lifesciences | 200.26B |
| Piramal Pharma | 197.65B |
| Cohance Lifesciences | 149.41B |
| Alivus Life Sciences | 131.28B |